These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2414254)

  • 1. Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck.
    Posner MR; Weichselbaum RR; Fitzgerald TJ; Clark JR; Rose C; Fabian RL; Norris CM; Miller D; Tuttle SA; Ervin TJ
    Int J Radiat Oncol Biol Phys; 1985 Nov; 11(11):1887-93. PubMed ID: 2414254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of aggressive multimodality therapy including cisplatinum, bleomycin and methotrexate with radiation and/or surgery for advanced head and neck cancer.
    Weichselbaum RR; Posner MR; Ervin TJ; Fabian RL; Miller D
    Int J Radiat Oncol Biol Phys; 1982 May; 8(5):909-13. PubMed ID: 6179911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy with high-dose methotrexate, bleomycin, and cisplatin in management of head and neck squamous cell carcinoma.
    Sridhar KS; Ohnuma T; Biller H; Holland JF; Ambinder EP; Barba J
    Am J Clin Oncol; 1985 Feb; 8(1):55-60. PubMed ID: 2581436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival.
    Kies MS; Haraf DJ; Athanasiadis I; Kozloff M; Mittal B; Pelzer H; Rademaker AW; Wenig B; Weichselbaum RR; Vokes EE
    J Clin Oncol; 1998 Aug; 16(8):2715-21. PubMed ID: 9704722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy used prior to radiation therapy for locally advanced squamous cell carcinoma of the head and neck.
    Tannock I; Cummings B; Sorrenti V
    Cancer Treat Rep; 1982 Jun; 66(6):1421-4. PubMed ID: 6177413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of hypothyroidism following multimodality treatment for advanced squamous cell cancer of the head and neck.
    Posner MR; Ervin TJ; Miller D; Fabian RL; Norris CM; Weichselbaum RR; Rose C
    Laryngoscope; 1984 Apr; 94(4):451-54. PubMed ID: 6708688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug chemotherapy (vincristine, bleomycin, and methotrexate [VBM]) with radiotherapy in stage III-IV squamous cell carcinoma of the head and neck.
    Rosso R; Merlano M; Sertoli MR; Campora E; Scarpati D; Borasi F; Pallestrini E
    Cancer Treat Rep; 1984; 68(7-8):1019-21. PubMed ID: 6204753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant administration of two standard regimens of chemotherapy and radiotherapy in advanced squamous carcinoma of the head and neck: a feasibility study.
    Benasso M; Corvò R; Numico G; Cavallari M; Blengio F; Sanguineti G; Rosso M; Merlano M
    Anticancer Res; 1995; 15(6B):2651-4. PubMed ID: 8669841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H; Tsukuda M; Taguchi T
    Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck.
    Ervin TJ; Clark JR; Weichselbaum RR; Fallon BG; Miller D; Fabian RL; Posner MR; Norris CM; Tuttle SA; Schoenfeld DA
    J Clin Oncol; 1987 Jan; 5(1):10-20. PubMed ID: 2433406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
    Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
    Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and late toxicity associated with sequential bleomycin-containing chemotherapy regimens and radiation therapy in the treatment of carcinoma of the nasopharynx.
    Peters LJ; Harrison ML; Dimery IW; Fields R; Goepfert H; Oswald MJ
    Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):623-33. PubMed ID: 2450858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
    Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
    J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck.
    Colevas AD; Norris CM; Tishler RB; Fried MP; Gomolin HI; Amrein P; Nixon A; Lamb C; Costello R; Barton J; Read R; Adak S; Posner MR
    J Clin Oncol; 1999 Nov; 17(11):3503-11. PubMed ID: 10550148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy.
    Merlano M; Vitale V; Rosso R; Benasso M; Corvò R; Cavallari M; Sanguineti G; Bacigalupo A; Badellino F; Margarino G
    N Engl J Med; 1992 Oct; 327(16):1115-21. PubMed ID: 1302472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.
    Colevas AD; Busse PM; Norris CM; Fried M; Tishler RB; Poulin M; Fabian RL; Fitzgerald TJ; Dreyfuss A; Peters ES; Adak S; Costello R; Barton JJ; Posner MR
    J Clin Oncol; 1998 Apr; 16(4):1331-9. PubMed ID: 9552034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
    Caponigro F; Comella P; Marcolin P; Russo Spena F; Biglietto M; Cartenì G; De Lucia L; Avallone A; Gravina A; Comella G
    Cancer; 1999 Feb; 85(4):952-9. PubMed ID: 10091775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.